Orion Investment Co

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 2033920 ST. LOUIS, MO

Position in IOVA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$8,624,520

+$1,374,082 QoQ

Shares Held

2,073,202

+0.4% QoQ

Ownership

0.458%

of shares outstanding

% of Portfolio

2.56%

of 13F equity value

Holder Rank

#29

of 292 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Orion Investment Co holds $49,855,819 across 4 Biotechnology names. IOVA ranks #3 (17.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	29,501	$18,395,053
2	IONS	Ionis Pharmaceuticals Inc	220,335	$17,470,362
3	IOVA	Iovance Biotherapeutics, Inc. This page	2,073,202	$8,624,520
4	ARWR	Arrowhead Pharmaceuticals, Inc.	65,831	$5,365,884

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,624,520	2,073,202	+0.4%	Shares	Sole	2026-08-11
2026-03-31	$7,250,438	2,065,652	+11.2%	Shares	Sole	2026-05-12
2025-12-31	$5,069,429	1,856,934	+0.3%	Shares	Sole	2026-02-11
2025-09-30	$4,018,371	1,851,784	-20.8%	Shares	Sole	2025-11-13
2025-06-30	$4,022,328	2,338,563	+98.7%	Shares	Sole	2025-08-14
2025-03-31	$3,918,920	1,176,853	+10.9%	Shares	Sole	2025-05-14
2024-12-31	$7,849,587	1,060,755	+17.0%	Shares	Sole	2025-02-13
2024-09-30	$8,510,016	906,285	+14.0%	Shares	Sole	2024-11-13
2024-06-30	$6,373,494	794,700	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.